Overview and Scope
Artificial intelligence in diabetes management refers to using AI technologies and algorithms to spot patterns in behavior that lead to either high or low blood sugar levels in diabetes patients. Artificial intelligence in diabetes management improves various aspects of diabetes care, including decision support, prediction, lifestyle guidance, and treatment management.
Sizing and Forecast
The artificial intelligence in diabetes management market size has grown exponentially in recent years. It will grow from $0.48 billion in 2023 to $0.63 billion in 2024 at a compound annual growth rate (CAGR) of 31.6%. The growth in the historic period can be attributed to data accumulation, rising diabetes cases, healthcare cost pressures, early ai applications.
The artificial intelligence in diabetes management market size is expected to see exponential growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 31.7%. The growth in the forecast period can be attributed to ai-powered decision support systems, telemedicine integration, genomic data utilization, regulatory support. Major trends in the forecast period include advancements in wearable technology, personalized treatment plans, continuous glucose monitoring advances, ai-powered risk prediction, behavioral modification support.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report
Segmentation & Regional Insights
The artificial intelligence in diabetes management market covered in this report is segmented –
1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes
North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2023. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp
Major Driver Impacting Market Growth
The rising prevalence of diabetes is expected to propel artificial intelligence in the diabetes management market going forward. Diabetes occurs when the blood glucose, or blood sugar, is too high. Diabetes is a condition that causes various conditions such as eye problems, heart attacks and strokes, kidney problems, and others. Artificial intelligence is used to manage diabetes as it provides information about high or low blood sugar levels in a diabetic patient and collects data that has not been used previously. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, diabetes affected 537 million adults (20–79 years old) in 2021, and it is predicted that the number will climb to 643 million people by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes is driving the growth of artificial intelligence in the diabetes management market.
Key Industry Players
Major companies operating in the artificial intelligence in diabetes management market report are Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.
The artificial intelligence in diabetes management market report table of contents includes:
1. Executive Summary
2. Artificial Intelligence in Diabetes Management Market Characteristics
3. Artificial Intelligence in Diabetes Management Market Trends And Strategies
4. Artificial Intelligence in Diabetes Management Market – Macro Economic Scenario
5. Global Artificial Intelligence in Diabetes Management Market Size and Growth
.
.
.
32. Global Artificial Intelligence in Diabetes Management Market Competitive Benchmarking
33. Global Artificial Intelligence in Diabetes Management Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Artificial Intelligence in Diabetes Management Market
35. Artificial Intelligence in Diabetes Management Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
